This month’s edition analyzes and compares prescription volume and drug costs in the Medicaid and Medicare Part D programs. We tabulated pre-rebate cost per prescription for each program from 2013-2017.  We also analyzed trends in specialty drug volume and expenditures during the same time period for each program.